Simon Read, Chief Scientific Officer at Ra Pharmaceuticals, Inc. (RARX), sold 19,586 shares at $22.21 ($435K) on 2019-06-18, disclosed to the SEC on 2019-06-19.
Open-market sale of $435k RARX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.21 | 9,586 | $213K | 48.9% |
| 2 | $22.21 | 9,586 | $213K | 48.9% |
| 3 | $23.09 | 414 | $10K | 2.2% |
| Total | $22.23 avg | 19,586 | $435K | 100% |
| Filing → |
| RARX | SELL | 2019-12-18 | $471K | — | Filing → |
| RARX | SELL | 2019-11-18 | $467K | — | Filing → |
| RARX | SELL | 2019-10-17 | $469K | — | Filing → |